Cargando…

Star Allele-Based Haplotyping versus Gene-Wise Variant Burden Scoring for Predicting 6-Mercaptopurine Intolerance in Pediatric Acute Lymphoblastic Leukemia Patients

Nudix Hydrolase 15 (NUDT15) and Thiopurine S-Methyltransferase (TPMT) are strong genetic determinants of thiopurine toxicity in pediatric acute lymphoblastic leukemia (ALL) patients. Since patients with NUDT15 or TPMT deficiency suffer severe adverse drug reactions, star (*) allele-based haplotypes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Yoomi, Kim, Hyery, Choi, Jung Yoon, Yun, Sunmin, Min, Byung-Joo, Seo, Myung-Eui, Im, Ho Joon, Kang, Hyoung Jin, Kim, Ju Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580331/ https://www.ncbi.nlm.nih.gov/pubmed/31244663 http://dx.doi.org/10.3389/fphar.2019.00654

Ejemplares similares

APEX1 Polymorphism and Mercaptopurine-Related Early Onset Neutropenia in Pediatric Acute Lymphoblastic Leukemia
por: Kim, Hyery, et al.
Publicado: (2018)

Homozygote CRIM1 variant is associated with thiopurine-induced neutropenia in leukemic patients with both wildtype NUDT15 and TPMT
por: Park, Yoomi, et al.
Publicado: (2020)

Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
por: Zhou, Hong, et al.
Publicado: (2018)

Interplay between IL6 and CRIM1 in thiopurine intolerance due to hematological toxicity in leukemic patients with wild-type NUDT15 and TPMT
por: Kim, Hyery, et al.
Publicado: (2021)

An international retrospective study for tolerability of 6-mercaptopurine on NUDT15 bi-allelic variants in children with acute lymphoblastic leukemia
por: Tanaka, Yoichi, et al.
Publicado: (2021)

Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization.
por: Lilleyman, J. S., et al.
Publicado: (1984)

Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia
por: Alsous, Mervat, et al.
Publicado: (2017)

Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia
por: Zhang, Melissa, et al.
Publicado: (2019)

Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?
por: Lennard, L., et al.
Publicado: (1993)

Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance?
por: Lennard, L., et al.
Publicado: (1995)

Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia: Clinical Facts and Fiction
por: Schmiegelow, Kjeld, et al.
Publicado: (2014)

Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia
por: Conneely, Shannon E., et al.
Publicado: (2020)

Screening of Novel Pharmacogenetic Candidates for Mercaptopurine-Induced Toxicity in Patients With Acute Lymphoblastic Leukemia
por: Cao, Minyuan, et al.
Publicado: (2020)

Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells
por: Panetta, J C, et al.
Publicado: (2006)

The Effect of NUDT15, TPMT, APEX1, and ITPA Genetic Variations on Mercaptopurine Treatment of Pediatric Acute Lymphoblastic Leukemia
por: Lee, Jae Min, et al.
Publicado: (2021)

Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia
por: Farfan, Mauricio J, et al.
Publicado: (2014)

Severe recurrent nocturnal hypoglycemia during chemotherapy with 6-mercaptopurine in a child with acute lymphoblastic leukemia
por: Cho, Eun Mi, et al.
Publicado: (2018)

The influence of NUDT15 variants on 6-mercaptopurine-induced neutropenia in Vietnamese pediatric acute lymphoblastic leukemia
por: Nguyen, Mai-Lan, et al.
Publicado: (2023)

Preparation, Characterization, Pharmacokinetic, and Therapeutic Potential of Novel 6-Mercaptopurine-Loaded Oral Nanomedicines for Acute Lymphoblastic Leukemia
por: Zou, Yaru, et al.
Publicado: (2021)

TPMT*3C as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia
por: Jantararoungtong, Thawinee, et al.
Publicado: (2021)

Distribution of HLA class I alleles and haplotypes in Korean.
por: Kim, T. G., et al.
Publicado: (1993)

Evaluation of exome variants using the Ion Proton Platform to sequence error-prone regions
por: Seo, Heewon, et al.
Publicado: (2017)

ENHANCEMENT OF ANTIBODY SYNTHESIS BY 6-MERCAPTOPURINE
por: Chanmougan, Devendrathan, et al.
Publicado: (1966)

SUPPRESSION OF ALLERGIC UVEITIS BY 6-MERCAPTOPURINE
por: Wirostko, E., et al.
Publicado: (1962)

Design and development of hydrogel nanoparticles for mercaptopurine
por: Senthil, V., et al.
Publicado: (2010)

The effects of 6-mercaptopurine nucleotide derivatives on the growth and survival of 6-mercaptopurine-sensitive and -resistant cell culture lines.
por: Johnston, H. P., et al.
Publicado: (1985)

ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia
por: Moradveisi, Borhan, et al.
Publicado: (2019)

STUDIES ON THE ANTI-INFLAMMATORY ACTION OF 6-MERCAPTOPURINE
por: Hurd, Eric R., et al.
Publicado: (1968)

EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: THE EFFECT OF 6-MERCAPTOPURINE
por: Hoyer, Leon W., et al.
Publicado: (1962)

Crystal structures of five 6-mercaptopurine derivatives
por: Gomes, Lígia R., et al.
Publicado: (2016)

PolyHaplotyper: haplotyping in polyploids based on bi-allelic marker dosage data
por: Voorrips, Roeland E., et al.
Publicado: (2022)

Variants in TPMT, ITPA, ABCC4 and ABCB1 Genes As Predictors of 6-mercaptopurine Induced Toxicity in Children with Acute Lymphoblastic Leukemia
por: Milosevic, Goran, et al.
Publicado: (2018)

Effects of TPMT, NUDT15, and ITPA Genetic Variants on 6-Mercaptopurine Toxicity for Pediatric Patients With Acute Lymphoblastic Leukemia in Yunnan of China
por: Mao, Xiaoyan, et al.
Publicado: (2021)

Incidence and determinants of hematotoxicity in acute lymphoblastic leukemia children who received 6-mercaptopurine based maintenance therapy in Addis Ababa, Ethiopia
por: Ali, Awol Mekonnen, et al.
Publicado: (2023)

Most parsimonious haplotype allele sharing determination
por: Cai, Zhipeng, et al.
Publicado: (2009)

Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study
por: Koh, Kyung-Nam, et al.
Publicado: (2017)

A minor allele of the haplotype located in the 19q13 loci is associated with a decreased risk of hyper-LDL-cholesterolemia, and a balanced diet and high protein intake can reduce the risk
por: Park, Sunmin, et al.
Publicado: (2020)

An efficient genotyper and star-allele caller for pharmacogenomics
por: Hari, Ananth, et al.
Publicado: (2023)

Long-term treatment outcomes of children and adolescents with lymphoblastic lymphoma treated with various regimens: a single-center analysis
por: Choi, Ho Jung, et al.
Publicado: (2020)

THE EFFECT OF 6-MERCAPTOPURINE ON DELAYED HYPERSENSITIVITY IN GUINEA PIGS
por: Hoyer, John R., et al.
Publicado: (1962)

Cannot write session to /tmp/vufind_sessions/sess_f54muj7pr05kvc2191no9j888d